3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
7
Completed
4
Recruiting
3
Terminated
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
31
Melanoma
20
Neoplasms
13
Breast Neoplasms
11
Stomach Neoplasms
9
Pancreatic Neoplasms
9
Neoplasm Metastasis
9
Lung Neoplasms
9
Head and Neck Neoplasms
9
Triple Negative Breast Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
8
Ovarian Neoplasms
8
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Carcinoma, Hepatocellular
6
Prostatic Neoplasms
4
Hodgkin Disease
4
Glioblastoma
4
Carcinoma, Transitional Cell
4
Carcinoma
4
Uterine Cervical Neoplasms
3
Liver Neoplasms
3
Kidney Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Adenocarcinoma
3
Small Cell Lung Carcinoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms, Squamous Cell
2
Mesothelioma
2
Interventions
Cisplatin
6
Radiotherapy
5
Surveys and Questionnaires
4
Paclitaxel
3
Surgical Procedures, Operative
2
Physical Examination
2
Gemcitabine
2
Drug Therapy
2
Docetaxel
2
Cetuximab
2
Blood Specimen Collection
2
pembrolizumab
1
nimotuzumab
1
fluoromisonidazole
1
fludarabine
1
durvalumab
1
Rubidium-82
1
Ropivacaine
1
Ritonavir
1
Nivolumab
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
Lidocaine
1
Interviews as Topic
1
Indinavir
1
Immunotherapy
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Oropharyngeal Neoplasms
×
pembrolizumab
×
Clear all
NCT04359199
2023-02-10
QUASAR
University of California, San Diego
Unknown
42 enrolled